-+ 0.00%
-+ 0.00%
-+ 0.00%

NASUS PHARMA - PIVOTAL STUDY PLANNED FOR Q4 2026; TOPLINE DATA READOUT ANTICIPATED Q1 2027

Reuters·09/14/2026 12:00:00

Please log in to view news